keyword
https://read.qxmd.com/read/38652377/simultaneous-occurrence-of-autoimmune-hepatitis-and-autoimmune-hemolytic-anemia-after-covid-19-infection-case-report-and-literature-review
#1
JOURNAL ARTICLE
Ryo Abe, Naoyuki Hasegawa, Satoshi Suzuki, Sakiko Shigeta, Ryota Matsuoka, Takayasu Kato, Yusuke Niisato, Emiko Seo, Daisuke Matsubara, Kiichiro Tsuchiya
Various autoimmune diseases have been reported to develop as a result of a coronavirus disease 19 (COVID-19) infection. There have been some reports of COVID-19-triggered autoimmune hepatitis and autoimmune hemolytic anemia infection, but none have reported simultaneous onset of these diseases. A 15-year-old girl was admitted to our hospital with severe liver injury and anemia. Three weeks before admission, her father was diagnosed with COVID-19, after which she became aware of a sore throat. Two weeks later, she visited her doctor for malaise...
April 23, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38650536/recurrent-disease-after-pediatric-renal-transplantation
#2
REVIEW
Anjali Nayak, Robert Ettenger, Katherine Wesseling-Perry
BACKGROUND: Recurrent disease after kidney transplant remains an important cause of allograft failure, accounting for 7-8% of graft loss and ranking as the fifth most common cause of allograft loss in the pediatric population. Although the pathophysiology of many recurrent diseases is incompletely understood, recent advances in basic science and therapeutics are improving outcomes and changing the course of several of these conditions. METHODS: Review of the literature...
May 2024: Pediatric Transplantation
https://read.qxmd.com/read/38644989/hepatosplenic-alpha-beta-t-cell-lymphoma-a-challenging-diagnostic-entity
#3
Abanoub Gabra, Joanna Polanco, Shrija Thapa, Sumit Sawhney, Alexey Glazyrin
Hepatosplenic T-cell lymphoma (HSTCL) is rare and clinically very aggressive T-cell lymphoma. The majority of cases harbor γδ T-cell receptors (TCRs); however, in some even rarer cases, tumor cells harbor αβ TCR. Recent studies suggest that αβ cases may have distinct morphological characteristics and demonstrate an even more aggressive course. In this case report, we demonstrated that in line with previous findings, αβ case of HSTCL had hemolytic presentation, demonstrated a very aggressive clinical course, and was unrelated to immunosuppression...
April 2024: Journal of Hematology (Brossard, Quebec)
https://read.qxmd.com/read/38644611/early-diagnosis-of-sickle-cell-retinopathy-by-using-ocular-coherence-tomography-in-pediatric-population-7-18-years-in-central-india
#4
JOURNAL ARTICLE
Pooja Soni, Bhavna Dhingra, Samendra Karkhur, Narendra K Chaudhary, Abhijit P Pakhare
BACKGROUND: Sickle cell disease (SCD) is the commonest inherited blood disorder leading to complications occurring due to vaso-occlusion including sight-threatening retinopathy. Retinopathy can be managed if diagnosed early and vision loss can be prevented. Since, very less data are available from India, hence, this study was conducted in children (7-18 years) with SCD to diagnose retinopathy by using ocular coherence tomography (OCT) in subclinical stages. METHODS: This cross sectional single-center study was performed in 7-18 years age group children with SCD without any visual symptoms...
April 21, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38642787/decellularized-kidney-extracellular-matrix-based-hydrogels-for-renal-tissue-engineering
#5
JOURNAL ARTICLE
Rita Quinteira, Sara Gimondi, Nelson O Monteiro, Rita Sobreiro-Almeida, Laura Lasagni, Paola Romagnani, Nuno M Neves
Kidney regeneration is hindered by the limited pool of intrinsic reparative cells. Advanced therapies targeting renal regeneration have the potential to alleviate the clinical and financial burdens associated with kidney disease. Delivery systems for cells, extracellular vesicles, or growth factors aimed at enhancing regeneration can benefit from vehicles enabling targeted delivery and controlled release. Hydrogels, optimized to carry biological cargo while promoting regeneration, have emerged as promising candidates for this purpose...
April 18, 2024: Acta Biomaterialia
https://read.qxmd.com/read/38641552/cabot-rings-in-a-cat-with-myeloproliferative-disease
#6
Mizuki Fujimoto, Masashi Takahashi, Tatsuro Hifumi, Akira Yabuki, Yu Furusawa, Hitoshi Hatai, Yasuyuki Endo
A 6-year-old spayed female Scottish Fold cat presented with lethargy and anorexia. A complete blood cell count indicated severe anemia and mild thrombocytopenia. Examination of peripheral blood smears revealed marked changes in the erythroid lineage, including the presence of basophilic stippling and Howell-Jolly bodies as well as an increase in nucleated erythrocytes, polychromatophils, ovalocytes, and schistocytes. Additionally, some erythrocytes contained a ring or figure-eight shaped structure known as a Cabot ring, which were especially observed in polychromatophilic erythrocytes...
April 19, 2024: Veterinary Clinical Pathology
https://read.qxmd.com/read/38640339/biased-agonism-of-protease-activated-receptor-1-regulates-thrombo-inflammation-in-murine-sickle-cell-disease
#7
JOURNAL ARTICLE
Nirupama Ramadas, Kailyn Lowder, Joshua Dutton, Fatima Trebak, Camille Faes, John H Griffin, Rafal Pawlinski, Laurent O Mosnier, Erica M Sparkenbaugh
Sickle cell disease (SCD) is a hereditary hemoglobinopathy marked by hemolytic anemia and vaso-occlusive events (VOE). Chronic endothelial activation, inflammation, and coagulation activation contribute to vascular congestion, VOE, and end-organ damage. Coagulation proteases like thrombin and activated protein C (APC) modulate inflammation and endothelial dysfunction by activating protease-activated receptor 1 (PAR1), a G-protein coupled receptor. Thrombin cleaves PAR1 at Arg41, while APC cleaves PAR1 at Arg46, initiating either pro-inflammatory or cytoprotective signaling, respectively, a signaling conundrum known as biased agonism...
April 19, 2024: Blood Advances
https://read.qxmd.com/read/38638374/subnormal-serum-liver-enzyme-levels-a-review-of-pathophysiology-and-clinical-significance
#8
REVIEW
Elham M Youssef, George Y Wu
Subnormal levels of liver enzymes, below the lower limit of normal on local laboratory reports, can be useful diagnostically. For instance, subnormal levels of aminotransferases can be observed in vitamin B6 deficiency and chronic kidney disease. Subnormal alkaline phosphatase levels may indicate the presence of hypophosphatasia, Wilson's disease, deficiencies of divalent ions, or malnutrition. Subnormal levels of gamma glutamyl transferase may be seen in cases of acute intrahepatic cholestasis, the use of certain medications, and in bone disease...
April 28, 2024: Journal of Clinical and Translational Hepatology
https://read.qxmd.com/read/38634874/managing-anti-factor-h-antibody-associated-hemolytic-uremic-syndrome-time-for-consensus
#9
EDITORIAL
Priyanka Khandelwal, Arvind Bagga
No abstract text is available yet for this article.
April 18, 2024: Pediatric Nephrology
https://read.qxmd.com/read/38634345/anti-d-immunization-after-d-positive-platelet-transfusions-in-d-negative-recipients-a-systematic-review-and-meta-analysis
#10
REVIEW
Tamar Hubert, Jean Louis Kerkhoffs, Anneke Brand, Henk Schonewille
BACKGROUND: Anti-D can be formed after D-incompatible platelet transfusions due to contaminating D+ red blood cells. These antibodies are of particular importance in women of childbearing potential, because anti-D is most often involved in severe cases of hemolytic disease of the fetus and newborn. This systematic review determined the frequency of anti-D after D+ platelet transfusions and risk factors for D alloimmunization. STUDY DESIGN AND METHODS: Relevant literature was searched using PubMed, Embase and Web of Science until December 2022...
April 18, 2024: Transfusion
https://read.qxmd.com/read/38632123/anti-cfh-associated-hemolytic-uremic-syndrome-do-we-still-need-plasma-exchange
#11
JOURNAL ARTICLE
Marion Ferri, Federica Zotta, Roberta Donadelli, Claire Dossier, Charlotte Duneton, Carine El-Sissy, Véronique Fremeau-Bacchi, Thérésa Kwon, Lisa Quadri, Andrea Pasini, Anne-Laure Sellier-Leclerc, Marina Vivarelli, Julien Hogan
BACKGROUND: Between 5 and 50% of atypical hemolytic uremic syndrome (aHUS) cases in children are caused by autoantibodies against complement factor H (CFH). Given the acquired autoimmune nature of the disease, plasma exchange (PE) and various immunosuppressive treatments have been used. More recently, eculizumab has been proposed. METHODS: In this multicenter, retrospective study, we report outcomes of 12 children with anti-FH antibody-associated HUS treated with eculizumab associated with various immunosuppressive regimens...
April 17, 2024: Pediatric Nephrology
https://read.qxmd.com/read/38632101/generation-and-analysis-of-tpi-deficiency-zebrafish-model
#12
JOURNAL ARTICLE
Sun Piao, Li Ying, Liu Fan, Wang Lu
Triosephosphate isomerase deficiency (TPI DF) is a severe multisystem degenerative disease, manifested clinically as hemolytic anemia, neuromuscular abnormalities, and susceptibility to infection, frequently leading to death within 5 years of onset. There is a lack of effective clinical treatment as the pathogenesis underlying TPI DF remains largely unknown. In this study, we generate a transgenic zebrafish line [Tg(Ubi:TPI1E105D -eGFP)] with the human TPI1E105D (hTPI1E105D ) mutation, which is the most recurrent mutation in TPI DF patients...
March 20, 2024: Yi Chuan, Hereditas
https://read.qxmd.com/read/38631980/hla-dr-dq-associations-combined-with-plasmic-score-are-reliable-predictors-of-acquired-thrombotic-thrombocytopenic-purpura-attp-and-aid-in-differentiating-attp-from-other-thrombotic-microangiopathies
#13
JOURNAL ARTICLE
Soumya Pandey, Akul Shrivastava, Yanping Izak Harville, Michele Cottler-Fox, Terry O Harville
BACKGROUND: Thrombotic microangiopathies (TMA) are a group of disorders with overlapping clinical features that require urgent intervention. Treatment is based on the recognition of the TMA type, which is often challenging. The aim of this study was to identify specific HLA associations with different TMA types to aid rapid diagnosis and appropriate treatment, since the HLA assay can be completed within five hours. METHODS: All 86 consecutive patients who presented to the University of Arkansas for Medical Sciences between May 2013 and January 2021 with a presumptive diagnosis of TMA were included in this study...
February 8, 2024: Hematology, Transfusion and Cell Therapy
https://read.qxmd.com/read/38631156/in-depth-structure-function-profiling-of-the-complex-formation-between-clotting-factor-viii-and-heme
#14
JOURNAL ARTICLE
Marie-T Hopp, Deniz Ugurlar, Behnaz Pezeshkpoor, Arijit Biswas, Anuradha Ramoji, Ute Neugebauer, Johannes Oldenburg, Diana Imhof
BACKGROUND AND AIMS: Blood disorders, such as sickle cell disease, and other clinical conditions are often accompanied by intravascular hemolytic events along with the development of severe coagulopathies. Hemolysis, in turn, leads to the accumulation of Fe(II/III)-protoporphyrin IX (heme) in the intravascular compartment, which can trigger a variety of proinflammatory and prothrombotic reactions. As such, heme binding to the blood coagulation proteins factor VIII (FVIII), fibrinogen, and activated protein C with functional consequences has been demonstrated earlier...
April 13, 2024: Thrombosis Research
https://read.qxmd.com/read/38629875/employment-of-mastoparan-like-peptides-to-prevent-staphylococcus-aureus-associated-with-bovine-mastitis
#15
JOURNAL ARTICLE
Raquel M Q Orozco, Karen G N Oshiro, Ingrid B Pinto, Danieli F Buccini, Claudiane V Almeida, Valentina Nieto Marin, Camila Maurmann de Souza, Maria L R Macedo, Marlon H Cardoso, Octávio L Franco
Bovine mastitis is a frequent infection in lactating cattle, causing great economic losses. Staphylococcus aureus represents the main etiological agent, which causes recurrent and persistent intramammary infections because conventional antibiotics are ineffective against it. Mastoparan-like peptides are multifunctional molecules with broad antimicrobial potential, constituting an attractive alternative. Nevertheless, their toxicity to host cells has hindered their therapeutic application. Previously, our group engineered three mastoparan-L analogs, namely mastoparan-MO, mastoparan-R1, and [I5 , R8 ] MP, to improve cell selectivity and potential...
April 17, 2024: Journal of Bacteriology
https://read.qxmd.com/read/38623087/cost-utility-analysis-comparing-pegcetacoplan-to-anti-c5-monoclonal-antibodies-in-the-treatment-of-paroxysmal-nocturnal-hemoglobinuria
#16
JOURNAL ARTICLE
Sergio Di Matteo, Roberto Freilone, Giacomo Matteo Bruno, Rosario Notaro, Sabrin Moumene, Nicoletta Martone, Cristina Teruzzi, Antonio Ciccarone, Giorgio Lorenzo Colombo
BACKGROUND: Paroxysmal nocturnal hemoglobinuria is a rare, acquired disease characterized by hemolytic episodes and associated with significant clinical burden. The introduction of C5 inhibitory monoclonal antibodies (C5i) represented a major breakthrough in PNH treatment, effectively reducing intravascular hemolysis (IVH) but showing limited impact on extravascular hemolysis (EVH). In 2021, the C3 inhibitor pegcetacoplan was approved by EMA and recently reimbursed in Italy, which also has the advantages in the reduction of both IVH and EVH, increasing hemoglobin values and simultaneously improving the quality of life and fatigue of patients...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38618320/sars-cov-2-with-influenza-b-coinfection-in-a-patient-with-sickle-cell-hbsc-presenting-with-painful-crisis-a-case-report
#17
Elrazi A Ali, Abdalla Fadul, Eihab A Subahi, Mugtaba Ahmed, Ahmed Elamin, Malar Thwin, Edouard Guillaume
Sickle cell disease is a hereditary red blood cell disorder characterized by hemolytic anemia, particularly in association with stress. As they grow, most children with sickle cell anemia undergo auto-splenectomy, making them vulnerable to serious infections. Patients with sickle cell disease infected with the SARS-CoV-2 virus are reported to have an increased risk for hospitalization, thrombosis, and other complications compared to non-sickle cell patients. Influenza infection in patients with sickle cell is associated with increased morbidity...
March 2024: Curēus
https://read.qxmd.com/read/38607807/comparison-of-the-solid-phase-red-cell-adherence-assay-and-tube-method-for-detection-and-identification-of-red-blood-cell-antibodies
#18
JOURNAL ARTICLE
Mohamed Abdelmonem, Alex Dussaq, Kathy Papakonstantino, Muharrem Yunce, Mrigender Singh Virk
OBJECTIVES: Identifying antibodies to red blood cell antigens is one of transfusion medicine's critical responsibilities. The International Society of Blood Transfusion recognizes 354 red blood cell antigens. Accurate identification of clinically significant alloantibodies is imperative for preventing hemolytic transfusion reactions and hemolytic disease of the fetus and newborn. We compared the performance of the tube (polyethylene glycol-indirect antiglobulin test [PEG-IAT]) and solid-phase red cell adherence assay techniques...
April 12, 2024: American Journal of Clinical Pathology
https://read.qxmd.com/read/38605580/probiotic-properties-and-the-ameliorative-effect-on-dss-induced-colitis-of-human-milk-derived-lactobacillus-gasseri-shmb-0001
#19
JOURNAL ARTICLE
Xufei Wang, Fang Dong, Gaojie Liu, Lin Ye, Fangfei Xiao, Xiaolu Li, Ting Zhang, Yizhong Wang
Human milk contains a variety of microorganisms that exert benefit for human health. In the current study, we isolated a novel Lactobacillus gasseri strain named Lactobacillus gasseri (L. gasseri) SHMB 0001 from human milk and aimed to evaluate the probiotic characteristics and protective effects on murine colitis of the strain. The results showed that L. gasseri SHMB 0001 possessed promising potential probiotic characteristics, including good tolerance against artificial gastric and intestinal fluids, adhesion to Caco-2 cells, susceptibility to antibiotic, no hemolytic activity, and without signs of toxicity or infection in mice...
April 11, 2024: Journal of Food Science
https://read.qxmd.com/read/38604785/-expert-consensus-on-clonal-screening-and-monitoring-of-complement-inhibitor-therapy-in-paroxysmal-nocturnal-hemoglobinuria-2024
#20
JOURNAL ARTICLE
(no author information available yet)
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal disease with abnormal hematopoietic stem cells that causes intravascular hemolytic anemia, thrombosis, and peripheral blood cytopenia. It has a chronic progressive course and can be fatal in severe cases if not treated aggressively. Complement inhibitors are the first-line recommended treatment for hemolysis-related symptoms of PNH. With the rapid development of new complement inhibitors, it is critical to quickly screen and confirm the diagnosis, identify patients with complement inhibitor indications, and monitor breakthrough hemolysis and extravascular hemolysis during complement inhibitor therapy...
February 14, 2024: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
keyword
keyword
60267
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.